The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Signs and Symptoms of Tobacco Withdrawal
Abstract
To test the validity, magnitude, and clinical significance of the signs and symptoms of tobacco withdrawal defined by DSM-III, both observed and reported signs and symptoms were measured in 50 smokers during two days of ad lib smoking and then during the first four days of abstinence. Observer and subject ratings of the DSM-III symptoms of craving for tobacco, irritability, anxiety, difficulty concentrating, and restlessness increased after cessation. In addition, bradycardia, impatience, somatic complaints, insomnia, increased hunger, and increased eating occurred after cessation. The frequency and intensity of these symptoms varied across subjects; however, the average distress from tobacco withdrawal was similar to that observed in psychiatric outpatients. Subjects who had more withdrawal discomfort were more tolerant to the cardiovascular effects of nicotine. Subjects who had more withdrawal discomfort did not have a lower rate of smoking cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different types of syndromes have been described with the withdrawal from SSRIs and other CNS drug classes, including benzodiazepines, antipsychotics, antidepressants, opiates, barbiturates, and alcohol: (1) new withdrawal symptoms (classic withdrawal symptoms from CNS drugs) [1,[4][5][6][9][10][11][12] , (2) rebound [2,6,9,[13][14][15][16] , and (3) persistent postwithdrawal disorders [7,17,18] (”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [17]
In the citing paper
“Persistent postwithdrawal disorders or tardive receptor supersensitivity disorders have been described with the use of antipsychotic medication [7,17,18] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [17]
In the citing paper
“Tardive dyskinesia and supersensitivity psychosis are well-known postwithdrawal disorders (also called supersensitivity syndromes) [7,17,18] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [17]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,279
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
Reddy, M. V. (2014) · Apple Academic Press eBooks · doi:10.1201/b17560-26 · Cited by 12,121
Fagerström, K.-O. (1978) · Addictive Behaviors · doi:10.1016/0306-4603(78)90024-2 · Cited by 2,221
TOLERANCE TO, AND DEPENDENCE ON, SOME NON-OPIATE PSYCHOTROPIC DRUGS
Kalant, H., LeBlanc, A. E., & Gibbins, R. J. (1971) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06888-7 · Cited by 771
Smoking withdrawal symptoms in two weeks of abstinence
Shiffman, S. M., & Jarvik, M. E. (1976) · Psychopharmacology · doi:10.1007/bf00634151 · Cited by 542
Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine
Langone, J. J., Gjika, H. B., & Vunakis, H. V. (1973) · Biochemistry · doi:10.1021/bi00748a032 · Cited by 394
A Scale to Differentiate between Types of Smoking as Related to the Management of Affect
Ikard, F. F., Green, D. E., & Horn, D. (1969) · International Journal of the Addictions · doi:10.3109/10826086909062040 · Cited by 354
Effect of nicotine on the tobacco withdrawal syndrome
Hughes, J. R., Hatsukami, D. K., Pickens, R. W., Krahn, D. D., Malin, S., & Luknic, A. (1984) · Psychopharmacology · doi:10.1007/bf00427428 · Cited by 286
Self-citationTobacco withdrawal symptoms: An experimental analysis
Hatsukami, D. K., Hughes, J. R., Pickens, R. W., & Svikis, D. S. (1984) · Psychopharmacology · doi:10.1007/bf00427451 · Cited by 217
Self-citationHow a cigarette is smoked determines blood nicotine levels
Herning, R. I., Jones, R. T., Benowitz, N. L., & Mines, A. H. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.12 · Cited by 185
Cited by
Sorted by citations
Items 601–700 of 1,004
Flavor improvement does not increase abuse liability of nicotine chewing gum
Houtsmuller, E. J., Fant, R. V., Eissenberg, T., Henningfield, J. E., & Stitzer, M. L. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00723-2 · Cited by 41
Weinberger, A. H., Reutenauer, E. L., Jatlow, P. I., O’Malley, S. S., Potenza, M. N., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.009 · Cited by 41
Obligatory Cessation of Smoking by Psychiatric Inpatients
Smith, C. M., Pristach, C. A., & Cartagena, M. T. (1999) · Psychiatric Services · doi:10.1176/ps.50.1.91 · Cited by 41
Stoker, A. K., Olivier, B., & Markou, A. (2012) · Behavior Genetics · doi:10.1007/s10519-011-9511-0 · Cited by 40
Feldner, M. T., Vujanovic, A. A., Gibson, L. E., & Zvolensky, M. J. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.16.2.144 · Cited by 40
Ibrahim, C., Tang, V. M., Blumberger, D. M., Malik, S., Tyndale, R. F., Trevizol, A. P., Barr, M. S., Daskalakis, Z. J., Zangen, A., & Foll, B. L. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.10.002 · Cited by 37
A randomized controlled trial of a smoking cessation intervention conducted among prisoners
RICHMOND, R. L., Indig, D., Butler, T. G., Wilhelm, K. A., Archer, V., & WODAK, A. D. (2012) · Addiction · doi:10.1111/add.12084 · Cited by 40
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
Ashare, R. L., & Schmidt, H. D. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.908180 · Cited by 40
Rovina, N., Nikoloutsou, I., Katsani, G., Dima, E., Fransis, K., Roussos, C., & Gratziou, C. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809350653 · Cited by 42
Higgins, S. T., Bergeria, C. L., Davis, D. R., Streck, J. M., Villanti, A. C., Hughes, J. R., Sigmon, S. C., Tidey, J. W., Heil, S. H., Gaalema, D. E., et al. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.04.010 · Cited by 40
Self-citationAlcoholism risk, tobacco smoking, and P300 event-related potential
Polich, J. M., & Ochoa, C. J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.026 · Cited by 40
Carim-Todd, L., Mitchell, S. H., & Oken, B. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv210 · Cited by 42
Effects of Mecamylamine on Spontaneous EEG and Performance in Smokers and Non-Smokers
Pickworth, W. B. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00183-9 · Cited by 40
Lam, S., & Patel, P. N. (2007) · Cardiology in Review · doi:10.1097/01.crd.0000260270.12829.45 · Cited by 39
Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms
Pomerleau, C. S., Tate, J. C., Lumley, M. A., & Pomerleau, O. F. (1994) · Journal of Substance Abuse · doi:10.1016/s0899-3289(94)90376-x · Cited by 40
Bujarski, S., Roche, D. J. O., Sheets, E. S., Krull, J. L., Guzman, I., & Ray, L. A. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038861 · Cited by 40
“Participants rated three items from the Minnesota Nicotine Withdrawal Scale from 1 (none) to 5 (severe) (Etter & Hughes, 2006; Hughes & Hatsukami, 1986).”
Paz, R., Zvielli, A., Goldstein, P., & Bernstein, A. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.05.017 · Cited by 39
Piasecki, T. M., Piper, M. E., & Baker, T. B. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0020235 · Cited by 40
Baker, A., RICHMOND, R. L., Castle, D. J., Kulkarni, J., KAY‐LAMBKIN, F. J., Sakrouge, R., Filia, S., & Lewin, T. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802607147 · Cited by 39
Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes
Denlinger, R. L., Smith, T. T., Murphy, S. E., Koopmeiners, J. S., Benowitz, N. L., Hatsukami, D. K., Pacek, L. R., Colino, C., Cwalina, S. N., & Donny, E. C. (2016) · Tobacco Regulatory Science · doi:10.18001/trs.2.2.9 · Cited by 39
Heckman, B. W., MacQueen, D. A., Marquinez, N. S., MacKillop, J., Bickel, W. K., & Brandon, T. H. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000197 · Cited by 39
Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity
Miranda, R., Rohsenow, D. J., Monti, P. M., Tidey, J. W., & Ray, L. A. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.09.011 · Cited by 39
Craving-Induced EEG Reactivity in Smokers: Effects of Mood Induction, Nicotine Dependence and Gender
Knott, V., Naccache, L., Cyr, E., Fisher, D. J., McIntosh, J. F., Millar, A., & Villeneuve, C. M. (2008) · Neuropsychobiology · doi:10.1159/000201716 · Cited by 41
Motivational factors related to quitting smoking among prisoners during a smoking ban
Cropsey, K. L., & Kristeller, J. L. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00230-7 · Cited by 39
Preliminary Study of Buprenorphine and Bupropion for Opioid‐Dependent Smokers
Mooney, M. E., Poling, J. C., Gonzalez, G. M., Gonsai, K., Kosten, T. R., & Sofuoglu, M. (2008) · American Journal on Addictions · doi:10.1080/10550490802138814 · Cited by 39
Effects of doxepin on withdrawal symptoms in smoking cessation
Murphy, J. K., Edwards, N. B., Downs, A. D., Ackerman, B. J., & Rosenthal, T. L. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.10.1353 · Cited by 39
Kono, J., Miyata, H., Ushijima, S., Yanagita, T., Miyasato, K., 井川, 玄., & Hukui, K. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00143-4 · Cited by 38
Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers
Cropsey, K. L., Clark, C. B., Zhang, X., Hendricks, P. S., Jardin, B. F., & Lahti, A. C. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.03.014 · Cited by 38
An open-label pilot trial ofN-acetylcysteine and varenicline in adult cigarette smokers
McClure, E. A., Baker, N. L., Gipson, C. D., Carpenter, M. J., Roper, A. P., Froeliger, B., Kalivas, P. W., & Gray, K. M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.933839 · Cited by 38
Hooten, W. M., Townsend, C. O., Hays, J. T., Ebnet, K. L., Gauvin, T. R., Gehin, J. C., Laures, H. J., Patten, C. A., & Warner, D. O. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.010 · Cited by 38
Predicting smoking relapse with a multidimensional versus a single-item tobacco craving measure
Berlin, I., Singleton, E. G., & Heishman, S. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.03.017 · Cited by 42
Harrell, P. T., & Juliano, L. M. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0028652 · Cited by 38
Kozak, K., Sharif-Razi, M., Morozova, M., Gaudette, E. V., Barr, M. S., Daskalakis, Z. J., Blumberger, D. M., & George, T. P. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.015 · Cited by 38
Yamada, H., Bishnoi, M., Keijzers, K. F. M., van Tuijl, I. A., Small, E., Shah, H. P., Bauzo, R. M., Kobeissy, F. H., Sabarinath, S., & Derendorf, H. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.018 · Cited by 37
Evaluating the validities of different DSM‐IV‐based conceptual constructs of tobacco dependence*
Hendricks, P. S., Prochaska, J. J., Humfleet, G. L., & Hall, S. M. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02232.x · Cited by 38
Effects of smoking cessation on consumption of alcohol and sweet, high-fat foods
Perkins, K. A., Epstein, L. H., Sexton, J. E., & Pastor, S. (1990) · Journal of Substance Abuse · doi:10.1016/s0899-3289(10)80002-1 · Cited by 38
Cotinine: effects with and without nicotine
Hatsukami, D., Pentel, P. R., Jensen, J. A., Nelson, D. B., ALLEN, S. S., Goldman, A. I., & Raphael, D. E. (1998) · Psychopharmacology · doi:10.1007/s002130050495 · Cited by 38
Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers
Sofuoglu, M., Mouratidis, M., Yoo, S., Culligan, K., & Kosten, T. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0010-y · Cited by 38
Smokeless tobacco abstinence effects and nicotine gum dose
Hatsukami, D., Anton, D. J., Keenan, R. M., & Callies, A. L. (1992) · Psychopharmacology · doi:10.1007/bf02253589 · Cited by 38
Smits, J. A. J., Zvolensky, M. J., Rosenfield, D., Marcus, B. H., Church, T. S., Frierson, G. M., Powers, M. B., Otto, M. W., Davis, M. L., Hopkins, L. B., et al. (2012) · Trials · doi:10.1186/1745-6215-13-207 · Cited by 37
Sigmon, S., Miller, M. E., Meyer, A. C., Saulsgiver, K., Badger, G., Heil, S., & Higgins, S. (2016) · Addiction · doi:10.1111/add.13264 · Cited by 32
Liakoni, E., Edwards, K. C., Helen, G. S., Nardone, N., Dempsey, D. A., Tyndale, R. F., & Benowitz, N. L. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1238 · Cited by 37
Neural cue reactivity during acute abstinence predicts short‐term smoking relapse
Allenby, C. E., Falcone, M., Wileyto, E. P., Cao, W., Bernardo, L., Ashare, R. L., Janes, A. C., Loughead, J., & Lerman, C. E. (2019) · Addiction Biology · doi:10.1111/adb.12733 · Cited by 43
Edwards, K. C., Kasza, K. A., Tang, Z., Stanton, C. A., Sharma, E., Halenar, M. J., Taylor, K. A., Donaldson, E. A., Hull, L. C., Bansal‐Travers, M., et al. (2020) · Tobacco Control · doi:10.1136/tobaccocontrol-2020-055660 · Cited by 37
Metacognitions Across the Continuum of Smoking Dependence
Nikčević, A. V., & Spada, M. M. (2008) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465808004293 · Cited by 37
Sofuoglu, M., Waters, A. J., Mooney, M. E., & O’Malley, S. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.11.004 · Cited by 37
Rodríguez‐Artalejo, F., Urdinguio, P. J. L., Guallar‐Castillón, P., Dublang, P. G., Martínez, O. S., Azcárate, J. I. D., Alemán, M. F., & Banegas, J. R. (2003) · Occupational and Environmental Medicine · doi:10.1136/oem.60.5.358 · Cited by 37
Carroll, M. E., Lac, S. T., Asencio, M., & Keenan, R. M. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90025-8 · Cited by 37
Higgins, S. T., Heil, S. H., Sigmon, S. C., Tidey, J. W., Gaalema, D. E., Stitzer, M. L., Durand, H., Bunn, J. Y., Priest, J. S., Arger, C. A., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4438-z · Cited by 36
Measures and predictors of varenicline adherence in the treatment of nicotine dependence
Peng, A. R., Morales, M., Wileyto, E. P., Hawk, L. W., Cinciripini, P. M., George, T. P., Benowitz, N. L., Nollen, N. L., Lerman, C. E., Tyndale, R. F., et al. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.07.006 · Cited by 36
Enhanced pain perception prior to smoking cessation is associated with early relapse
Nakajima, M., & Al’Absi, M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.07.006 · Cited by 38
Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia
Dalack, G. W., & Meador‐Woodruff, J. H. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011151 · Cited by 38
Varenicline for smoking cessation: A review of the literature
Kaur, K., Kaushal, S., & Chopra, S. C. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.02.004 · Cited by 38
Marcus, B. H., Lewis, B. A., King, T. K., Albrecht, A. E., Hogan, J. W., Bock, B. C., Parisi, A. F., & Abrams, D. B. (2003) · Preventive Medicine · doi:10.1016/s0091-7435(02)00051-8 · Cited by 36
A randomized clinical trial of nicotine lozenge for smokeless tobacco use
Ebbert, J. O., Severson, H. H., Croghan, I. T., Danaher, B. G., & Schroeder, D. R. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp154 · Cited by 36
An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers
Stein, M. D., Caviness, C. M., Grimone, K., Audet, D., Anderson, B. J., & Bailey, G. L. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv267 · Cited by 38
Neuropeptide systems and new treatments for nicotine addiction
Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36
Kos, J., Hasenfratz, M., & Bättig, K. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00518-5 · Cited by 36
Effect of Acupuncture on Smoking Cessation or Reduction: An 8-Month and 5-Year Follow-up Study
He, D., Medbø, J. I., & Høstmark, A. T. (2001) · Preventive Medicine · doi:10.1006/pmed.2001.0901 · Cited by 36
Mild anxiogenic effects of nicotine withdrawal in mice
Jonkman, S., Henry, B., Semenova, S., & Markou, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.032 · Cited by 35
Dingle, G. A., & Carter, N. A. (2017) · Musicae Scientiae · doi:10.1177/1029864916682822 · Cited by 34
Subjective and physiological responses to smoking cues in smokers with schizophrenia
Tidey, J. W., Rohsenow, D. J., Kaplan, G. B., & Swift, R. M. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500125724 · Cited by 35
Circulating leptin levels are associated with increased craving to smoke in abstinent smokers
Al’Absi, M., Hooker, S. A., Fujiwara, K., Kiefer, F., von der Goltz, C., Cragin, T., & Wittmers, L. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.10.004 · Cited by 35
Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects
Faulkner, P., Ghahremani, D. G., Tyndale, R. F., Cox, C. M., Kazanjian, A. S., Paterson, N. E., Lotfipour, S., Hellemann, G., Petersen, N., Vigil, C., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.18 · Cited by 35
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms
Robinson, J. D., Lam, C. Y., Minnix, J. A., Wetter, D. W., Tomlinson, G. E., Minna, J. D., Chen, T. T.-L., & Cinciripini, P. M. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500427 · Cited by 35
Schepis, T. S., McFetridge, A. K., Chaplin, T. M., Sinha, R., & Krishnan‐Sarin, S. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr022 · Cited by 35
Acute Effects of Cigarillo Smoking
Blank, M. D., Nasim, A., Hart, A., & Eissenberg, T. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr070 · Cited by 35
Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine
Mendoza-Baumgart, M. I., Tulunay, O. E., Hecht, S. S., Zhang, Y., Murphy, S. E., Le, C. T., Jensen, J. A., & Hatsukami, D. K. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701704228 · Cited by 35
A test of proposed new tobacco withdrawal symptoms
Etter, J., USSHER, M. H., & Hughes, J. R. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03981.x · Cited by 36
Self-citationThe effect of chewing gum on tobacco withdrawal
Cohen, L. M., Collins, F. L., & Britt, D. M. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00072-x · Cited by 35
Loss of acute nicotine tolerance and severity of cigarette withdrawal
West, R., & Russell, M. A. (1988) · Psychopharmacology · doi:10.1007/bf00212856 · Cited by 35
Yu, X., Xiao, D., Li, B., Liu, Y., Wang, G., Chen, J., Bai, C., Pan, J., Wan, H., Li, Q. Y., et al. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq063 · Cited by 34
Minami, H., Brinkman, H. R., Nahvi, S., Arnsten, J. H., Mindt, M. R., Wetter, D. W., Bloom, E. L., Price, L. H., Vieira, C., Donnelly, R., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.12.014 · Cited by 34
Sonne, S. C., Nunes, E. V., Jiang, H., Tyson, C., Rotrosen, J., & Reid, M. S. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00015.x · Cited by 34
Oral tobacco products: Preference and effects among smokers
Hatsukami, D. K., Jensen, J. A., Anderson, A., Broadbent, B., ALLEN, S. S., Zhang, Y., & Severson, H. H. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.026 · Cited by 34
Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans
Zhdanova, I. V., & Piotrovskaya, V. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00302-6 · Cited by 34
Progressive Commercial Cigarette Yield Reduction: Biochemical Exposure and Behavioral Assessment
Benowitz, N. L., Dains, K. M., Hall, S. M., STEWART, S. L., Wilson, M., Dempsey, D. A., & Jacob, P. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0731 · Cited by 34
Semenova, S., Bespalov, A., & Markou, A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01904-6 · Cited by 34
Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum
Cherek, D. R., Bennett, R. H., & Grabowski, J. G. (1991) · Psychopharmacology · doi:10.1007/bf02246030 · Cited by 34
Leischow, S. J., Valente, S. N., Hill, A. L., Otte, P. S., Aickin, M. G., Holden, T., Kligman, E. W., & Cook, G. (1997) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.5.1.54 · Cited by 34
Predictors of Smoking Cessation in a Sample of Italian Smokers
Persico, A. M. (1992) · International Journal of the Addictions · doi:10.3109/10826089209068760 · Cited by 34
Distress intolerance during smoking cessation treatment
Farris, S. G., Leyro, T. M., Allan, N. P., Øverup, C. S., Schmidt, N. B., & Zvolensky, M. J. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.08.002 · Cited by 33
Kotlyar, M., Hertsgaard, L. A., Lindgren, B. R., Jensen, J. A., Carmella, S. G., Stepanov, I., Murphy, S. E., Hecht, S. S., & Hatsukami, D. K. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0349 · Cited by 33
Drug development in the light of translational science: shine or shade?
Wehling, M. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.008 · Cited by 32
Gross, J., Johnson, J. P., Sigler, L., & Stitzer, M. L. (1995) · Addictive Behaviors · doi:10.1016/0306-4603(94)00078-d · Cited by 33
The effects of smoking and smoking abstinence on verbal and visuospatial working memory capacity.
Greenstein, J. E., & Kassel, J. D. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0015699 · Cited by 36
Sex differences in response to reduced nicotine content cigarettes
Vogel, R. I., Hertsgaard, L. A., Dermody, S. S., Luo, X., Moua, L., ALLEN, S. S., Al’Absi, M., & Hatsukami, D. K. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.03.021 · Cited by 33
Assessment of nicotine withdrawal-induced changes in sucrose preference in mice
Alkhlaif, Y., Bağdaş, D., Jackson, A. B., Park, A. J., & Damaj, M. I. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.08.013 · Cited by 33
Neurobiological mechanisms of nicotine craving
Miyata, H., & Yanagita, T. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00144-6 · Cited by 35
History of depression and subsyndromal depression in women smokers
Borrelli, B., Marcus, B. H., Clark, M. M., Bock, B. C., King, T. K., & Roberts, M. B. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(99)00046-5 · Cited by 33
Substance Misuse and Psychiatric Comorbidity: towards improved service provision
CROME, I. B. (1999) · Drugs Education Prevention and Policy · doi:10.1080/09687639997115 · Cited by 33
The ‘nicotine replacement paradox’ in smoking cessation: how does nicotine gum really work?
West, R. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02689.x · Cited by 33
Christen, S. E., Hermann, L. L., Bekka, E., Vonwyl, C., Hammann, F., van der Velpen, V., Eap, C. B., Benowitz, N. L., Haschke, M., & Liakoni, E. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae074 · Cited by 32
Issa, J. S., Abe, T. O., Moura, S., Santos, P. C. J. L., & Pereira, A. C. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts230 · Cited by 32
Sensory reinforcement-enhancing effects of nicotine via smoking.
Perkins, K. A., & Karelitz, J. L. (2014) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0037823 · Cited by 32
Al-Jdani, S., Mashabi, S., Alsaywid, B. S., & Zahrani, A. A. (2018) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_142_17 · Cited by 34
Higgins, S. T., Nighbor, T. D., Kurti, A. N., Heil, S. H., Slade, E. P., Shepard, D. S., Solomon, L. J., Lynch, M. E., Johnson, H. K., Markesich, C., et al. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107012 · Cited by 32
Henningfield, J. E., & Zeller, M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0308-4 · Cited by 32
Sofuoglu, M., Herman, A. I., Mooney, M. E., & Waters, A. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1643-z · Cited by 32
Ashare, R. L., Kimmey, B. A., Rupprecht, L. E., Bowers, M. E., Hayes, M. R., & Schmidt, H. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.209 · Cited by 34
Metadata
- Authors
- Hughes, J. R.
- Affiliations
- University of Vermont (US)
- Corresponding author
- Hughes, John R.
- ORCID
- Hughes, John R.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1986-03-01
- Volume
- 43
- Issue
- 3
- Pages
- 289
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2110569081
- Cited by
- 1,669
- References
- 22
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 39 · 2023: 52 · 2022: 42 · 2021: 38 · 2020: 63 · 2019: 67 · 2018: 65 · 2017: 69 · 2016: 91 · 2015: 68 · 2014: 72 · 2013: 55 · 2012: 68
- FWCI
- 18.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA-02988-01)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine withdrawal, nicotine withdrawal symptoms, smoking cessation, nicotine tolerance, irritability, anxiety, craving, bradycardia, insomnia, dietary habits, observer ratings
- MeSH terms
- Adult, Mental Disorders, Chewing Gum, Female, Humans, Male, Manuals as Topic, Nicotine, Plants, Toxic, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Nicotiana, Tobacco Use Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review